Featured Speaker Heart Failure Now

Dr. Alexandro Zarruk

Family Doctor, Pierrefonds, QC

Dr. Alexandro Zarruk, Family Physician MD, MSc., FACP, FRCPC, Internal Medicine, talks about the benefits of GLP-1 therapy for patients with Type 2 diabetes.


Dr. Alexandro Ricardo Zarruk has been practicing in the West Island and Hudson for a little over 3 years. He graduated from Boston University where he completed a Residency in Internal Medicine with interest in Endocrinology. Dr. Alexandro Zarruk also completed training at the University of Ottawa. He is associated with the Lakeshore General Hospital and has offices in both Pierrefonds and Hudson.

Dr. Alexandro Zarruk is a member of the American College of Physician, Coalition of Family Physicians and Specialists of Ontario, American Medical Association, Canadian Society of Internal Medicine and Federation des Médecins Spécialistes du Québec. He is a fellow of Royal College of Physician and Surgeons of Canada and is certified by the American Board of Internal Medicine.

( Dr. Alexandro Zarruk, Family Doctor, Pierrefonds, QC ) is in good standing with the College of Physicians and Surgeons. Now Health Network

The Benefits of GLP-1s in Type 2 Diabetes

The class of medication called GLP-1 agonists are prescribed to patients suffering from diabetes type 2. They’re prescribed because they have several benefits in that type of population. They’re very good for sugar control.

They actually help with a little bit of blood pressure lowering (three to five points) and at the level of weight, that’s where we have great benefit because depending on which one you’re talking about, we’re talking about a 10- to 20-pound weight loss. Why? Because it helps you control your hunger in your brain.

The GLP-1 agonists class of medication can be used really rapidly in treatment of diabetes⁠—as quickly as after metformin. Why would I use it at that point? Because it has been shown that it actually can save some special cells in your pancreas called the beta cells to promote better insulin production long-term. So why not postpone a lack of insulin and the need of insulin?

All ⁠GLP-1 agonists that are on the market right now have proven to be safe. Not only in the general population, but also in patients that were suffering from heart disease, they had special studies in that population. So it is safe.

The real appropriate candidate for GLP-1 agonists is basically everybody with type 2 diabetes. Why is that? You get better control of your sugar, and we have benefits at the blood pressure level and at the level of the weight management. So everybody would benefit from a GLP-1 agonist.

Presenter: Dr. Alexandro Zarruk, Family Doctor, Pierrefonds, QC

Local Practitioners: Family Doctor

Heart Failure Now

Heart Failure Now

QA Chat
Ask us a health question on
diagnosis/treatment options...